| Indicators | Browse All

VivoSim Labs, Inc. (VIVS)

Healthcare | Biotechnology | San Diego, United States | NasdaqCM
0.17 USD +0.01 (6.277%) ⇧ (Oct. 15, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 4:10 a.m. EDT

The immediate outlook is severely clouded by a relentless multi-year decline where the stock has lost 99.67% of its value over the last nine years, with five consecutive years of negative performance ending recently. While recent headlines highlight successful distribution deals in Asia and a new paid order from Chinese firms, these operational milestones have failed to arrest the bleeding, evidenced by a trailing twelve-month revenue contraction of 51.4% and a current price trading significantly below its 50-day and 200-day moving averages. The balance sheet is fragile, showing negative book value and substantial free cash outflows, while the statistical forecast model leans further negative with low confidence, suggesting the market remains unconvinced by the latest catalysts. There is no dividend to provide any income cushion, making this a high-risk speculative vehicle rather than an investment opportunity.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.118808
AutoARIMA0.192594
AutoETS0.462055
MSTL0.862887

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 41%
H-stat 0.12
Ljung-Box p 0.000
Jarque-Bera p 0.602
Excess Kurtosis 0.37
Attribute Value
Sector Healthcare
Revenue per Share 0.034
Market Cap 2,836,290
Beta 1.49
Previous Name Organovo Holdings, Inc.
Website https://vivosim.ai

Info Dump

Attribute Value
52 Week Change -0.93359375
Address1 11,555 Sorrento Valley Road
Address2 Suite 100
All Time High 3,276.0
All Time Low 0.15
Ask 0.1989
Ask Size 1
Average Daily Volume10 Day 885,670
Average Daily Volume3 Month 3,935,618
Average Volume 3,935,618
Average Volume10Days 885,670
Beta 1.49
Bid 0.1496
Bid Size 1
Book Value -0.734
City San Diego
Compensation As Of Epoch Date 1,798,675,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.171
Current Ratio 1.704
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 0.19
Day Low 0.1495
Display Name VivoSim Labs
Dividend Date 1,597,795,200
Dividend Yield 0.0
Earnings Timestamp End 1,754,683,200
Earnings Timestamp Start 1,754,337,600
Ebitda -11,137,000
Ebitda Margins 0.0
Enterprise To Ebitda -0.106
Enterprise To Revenue 10.584
Enterprise Value 1,185,454
Eps Trailing Twelve Months -4.47
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.2616
Fifty Day Average Change -0.090599984
Fifty Day Average Change Percent -0.34633023
Fifty Two Week Change Percent -93.359375
Fifty Two Week High 3.4
Fifty Two Week High Change -3.229
Fifty Two Week High Change Percent -0.9497059
Fifty Two Week Low 0.1495
Fifty Two Week Low Change 0.021500006
Fifty Two Week Low Change Percent 0.14381276
Fifty Two Week Range 0.1495 - 3.4
Financial Currency USD
First Trade Date Milliseconds 1,329,229,800,000
Float Shares 14,463,605
Free Cashflow -7,575,375
Full Exchange Name NasdaqCM
Full Time Employees 15
Fullday Change -0.008900002
Fullday Change Percent -5.204679
Fullday Price 0.1621
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Gross Profits -4,208,000
Has Pre Post Market Data 1
Held Percent Insiders 0.026659999
Held Percent Institutions 0.11088
Implied Shares Outstanding 16,586,495
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,774,915,200
Last Split Date 1,742,515,200
Last Split Factor 1:12
Long Business Summary VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and build functional 3D human tissues through its proprietary technologies that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Long Name VivoSim Labs, Inc.
Market us_market
Market Cap 2,836,290
Market State PRE
Max Age 86,400
Message Board Id finmb_106718277
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-10-16
Net Income To Common -12,338,000
Next Fiscal Year End 1,806,451,200
Non Diluted Market Cap 3,078,542
Open 0.157
Operating Cashflow -10,100,000
Operating Margins -153.27779
Payout Ratio 0.0
Phone 858 224 1000
Pre Market Change -0.008900002
Pre Market Change Percent -5.204679
Pre Market Price 0.1621
Pre Market Time 1,792,154,665
Prev Name Organovo Holdings, Inc.
Previous Close 0.1609
Price Hint 4
Price To Book -0.23297003
Price To Sales Trailing12 Months 25.324018
Profit Margins 0.0
Quick Ratio 0.898
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0101
Regular Market Change Percent 6.2772
Regular Market Day High 0.19
Regular Market Day Low 0.1495
Regular Market Day Range 0.1495 - 0.19
Regular Market Open 0.157
Regular Market Previous Close 0.1609
Regular Market Price 0.171
Regular Market Time 1,792,094,400
Regular Market Volume 3,365,851
Return On Assets -0.89502
Return On Equity -3.43103
Revenue Growth -0.514
Revenue Per Share 0.034
Sand P52 Week Change 0.16207206
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 16,586,495
Shares Percent Shares Out 0.0427
Shares Short 707,866
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 706,772
Short Name VivoSim Labs, Inc.
Short Percent Of Float 0.0427
Short Ratio 0.78
Source Interval 15
State CA
Symbol VIVS
Total Cash 1,670,000
Total Cash Per Share 0.112
Total Debt 316,000
Total Revenue 112,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -4.47
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.17345
Two Hundred Day Average Change -1.00245
Two Hundred Day Average Change Percent -0.8542758
Type Disp Equity
Volume 3,365,851
Website https://vivosim.ai
Zip 92,121